Publications

2024

Petra L Graham, Deborah J Schofield, Robert J Tait, Sarita Bista, Rebecca Q Ivers5, Bette Liu, Sharyn Lymer, Jennifer L Marino, Lena A Sanci, Rupendra N Shrestha, Katharine Steinbeck, Leon M Straker, S Rachel Skinner (2024) Adolescent risk behaviours are associated with educational attainment in early adulthood: Results from The Raine Study cohort, BMC Public Health, BMC Public Health, 24, 1, p. 2728.  doi: 10.1186/s12889-024-20208-2

Christopher Owens, Owen Tan, Joice Kuroiwa-Trzmielina, Rupendra N. Shrestha, Tracey O’Brien, Vanessa Tyrrell, Deborah J Schofield (2024) The economic costs of precision medicine for clinical translational research among children with high-risk cancer, npj Precision Oncology 2024, vol 8, issue 1, 2024, p. 224.  https://doi.org/10.1038/s41698-024-00711-w

S Haque, K Crawley, D Schofield, R Shrestha, C M Sue (2024) Cascade testing in mitochondrial diseases: a cross-sectional retrospective study. BMC Neurology Open. vol 24, issue 1, 2024, p. 343.  doi

Sameen Haque, Karen Crawley, Deborah Schofield, Rupendra Shrestha, Ryan Davis, Carolyn M Sue - Social provisions in patients with mitochondrial diseases: BMJ Neurology Open 2024;6:e000770. doi:10.1136/ bmjno-2024-000770

Haque S, Crawley K, Davis R, Schofield D, Shrestha R, Sue CM. (2024) Clinical drivers of hospitalisation in patients with mitochondrial diseases. BMJ Neurol Open. 2024 Jun 11;6(1):e000717. doi: 10.1136/bmjno-2024-000717. PMID: 38868460; PMCID: PMC11168164.

Schofield D, Lim K, Tanton R, Vermann L, Kelly S, Passey M, Shrestha R (2024) Economic impact of informal caring for a person with arthritis in Australia from 2015 to 2030: a microsimulation approach using national survey data. BMJ Open, 2024, 14:e076966 doi:10.1136/bmjopen-2023-076966

Deborah Schofield, Rupendra Shrestha, Owen Tan*, Katherine Lim, Radhika Rajkumar, Sarah West, Jackie Boyle, Lucinda Murray, Melanie Leffler, Louise Christie, Morgan Rice, Natalie Hart, JinJing Li, Robert Tanton, Tony Roscioli, Mike Field. (2024) The Healthcare and Societal Costs of Familial Intellectual Disability. Int. J. Environ. Res. Public Health 2024, 21, 299. https://doi.org/10.3390/ijerph21030299

Myra B McGuinness, Lauren N Ayton, Deborah Schofield, Alexis Ceecee Britten-Jones, Fred K Chen, John R Grigg, Ziyi Qi, Joshua Kraindler, Rupendra Shrestha, Heather G Mack (2024) EQ-5D-5L health utility scores in Australian adults with inherited retinal diseases: a cross-sectional survey Acta Ophthalmologica (online 16 January 2024)  https://doi.org/10.1111/aos.16634

Laura E Simons; Lauren E Harrison; Derek B Boothroyd; Gomathy Parvathinathan; Amanda R Van Orden; Shannon F O'Brien; Deborah Schofield; Joshua Kraindler; Rupendra Shrestha; Johan W S Vlaeyen et al. (2024) A randomized controlled trial of graded exposure treatment (GET living) for adolescents with chronic pain. Pain. 165(1):p 177-191 (online 25 August 2023) DOI 10.1097/j.pain.0000000000003010

Dias KR, Shrestha R, Schofield D, et al. Narrowing the diagnostic gap: Genomes, episignatures, long-read sequencing, and health economic analyses in an exome-negative intellectual disability cohort. Genet Med. 2024;26(5):101076. doi:10.1016/j.gim.2024.101076 PMID: 38258669.  PMID: 38258669.

2023

Anonnya Rizwana Chowdhury; Deborah Schofield; Rupendra Shrestha; Michael Nicholas (2023) Cost- Effectiveness Analysis of ADAPT, an Interdisciplinary Pain Self-Management Program. Pain (accepted 8/23)

Haque, S; Crawley, K; Shrestha, R; Schofield, D; Sue, C (2023) Healthcare resource utilization of patients with mitochondrial disease in an outpatient hospital setting. Orphanet Journal of Rare Diseases. 2023;18,129 https://doi.org/10.1186/s13023-023-02746-x

Schofield D, Kraindler J, Tan O, Shrestha RN, West S, Hart N, Tan L, Ma A, Grigg JR, Jamieson RV. The health care and societal costs of inherited retinal diseases in Australia: a microsimulation modelling study. Med J Aust. 2023 Jun 10. DOI: 10.5694/mja2.51997 Epub ahead of print. PMID: 37301731.

Anonnya Rizwana Chowdhury; Deborah Schofield; Rupendra Shrestha; Michael Nicholas (2023) Economic analysis of patient-related effects of an interdisciplinary pain self-management program. Pain 2023 Nov 1;164(11):2491-2500. DOI: 10.1097/j.pain.0000000000002959 PMID: 37326690 PMCID: PMC10578420

Schofield D, Lee E, Parmar J, Kelly S, Hobbs M, Laing N, Mumford J, Shrestha R (2023) Economic evaluation of population-based  preconception carrier screening for genetic diseases in Australia. Genetics in Medicine (2023) 25, 100813 DOI 10.1016/j.gim.2023.100813

2022

D Schofield, K Lim, O Tan, R Shrestha, S Haque, K Crawley, S West, A Percival, J Parmar, J Kraindler, J Li, R Tanton, C Sue (2022) The Development of a Microsimulation Model (MitoMOD) to Estimate the Economic Impact of Mitochondrial Disease in Adults. International Journal of Microsimulation. 15(2); 102-111. DOI: 10.34196/IJM.00265

Hunter DJ, Bowden JL, Hinman RS, Egerton T, Briggs AM, Bunker SJ, French SD, Pirotta M, Shrestha R, Schofield DJ, Schuck K, Zwar NA, Silva SSM, Heller GZ, Bennell KL; PARTNER Study Team. (2022) Effectiveness of a new service delivery model for management of knee osteoarthritis in primary care: a cluster randomised controlled trial. Arthritis Care Res (Hoboken). 2022 Oct 7. DOi: 10.1002/acr.25037. Epub ahead of print. PMID: 36205225.

Lisa J Ewans, Andre . Minoche, Deborah Schofield, Rupendra Shrestha, Clare Puttick, Ying Zhu, Alexander Drew, Velimir Gayevskiy, George Elakis, Corrina Walsh, Lesley C Adѐs, Alison Colley, Carolyn Ellaway, Carey-Anne Evans, Mary-Louise Freckmann, Linda Goodwin, Anna Hackett, Benjamin Kamien, Edwin P Kirk, Michelle Lipke, David Mowat, Elizabeth Palmer, Sulekha Rajagopalan, Anne Ronan, Rani Sachdev, William Stevenson, Anne Turner, Meredith Wilson, Lisa Worgan, Marie-Christine Morel-Kopp, Michael Field, Michael F Buckley, Mark J Cowley, Marcel E Dinger, Tony Roscioli.(2022) Whole Exome and Genome Sequencing in Mendelian Disorders: A Diagnostic and Health Economic Analysis’. European Journal of Human Genetics (2022) Vol 30, pp1121–1131. DOI 10.1038/s41431-022-01162-2

Deborah Schofield, Melanie J B Zeppel, Robert Tanton, Jacob Lennert Veerman, Simon J Kelly, Megan E Passey and Rupendra N Shrestha (2022) Individual and national financial impacts of informal caring for people with mental illness in Australia, projected to 2030. BJPsych Open Vol 8, e136, 1–6. doi: 10.1192/bjo.2022.540

Deborah Schofield, Joshua Kraindler, Owen Tan, Rupendra Shrestha, Diana Jelovic, Sarah West, John Grigg, Robyn V Jamieson (2022) Patient-Reported Health-Related Quality of Life in Individuals with Inherited Retinal Diseases. Ophthalmology Science. Vol 2 (1), March 2022, 100106. DOI: 10.1016/j.xops.2021.100106

2021

Hah J, Lee E, Shrestha R, Pirrotta L, Huddleston J, Goodman S, Amanatullah D, Dirbas F, Carroll I, Schofield D (2021) Return to work and productivity loss after surgery: A health economic evaluation. International Journal of Surgery. 195:106100  https://doi.org/10.1016/j.ijsu.2021.106100

O Tan, D J Schofield, T O’Brien, T Trahair, R N Shrestha (2021) Modelling the Economic Impact of Next Generation Sequencing and Precision Medicine on Childhood Cancer Management—a Microsimulation Approach. International Journal of Microsimulation. 14(1); 73-91. DOI: 10.34196/IJM.00230

Tan O, Schofield D, Shrestha R (2021) An analysis of hospital costs for childhood cancer care in Australia. JNCCN—Journal of the National Comprehensive Cancer Network. 20 (2); 126-135. DOI: 10.6004/jnccn.2020.7802

2020

Schofield D, Tan O, Shrestha R, Rajkumar R, West S, Rice M, Kasparian N, Boyle J, Christie L, Leffler M, Murray L, Roscioli T, Field M. (2020) IDMOD: An Australian Microsimulation Model of the Lifetime Economic and Psychosocial Impacts of Familial Intellectual Disability. International Journal of Microsimulation. 2020; 13(1); 52–66 DOI: https://doi.org/10.34196/ijm.00212

Schofield D, Zeppel M, Staffieri S, Shrestha R, Jelovic D, Lee E, Jamieson R V (2020) Preimplantation genetic diagnosis for retinoblastoma survivors: a cost-effectiveness study. Reproductive Biomedicine and Society Online. June 2020, 10, 37-45. DOI:10.1016/j.rbms.2020.03.001

2019

Deborah Schofield, Melanie Zeppel, Robert Tanton, Lennert Veerman, Simon Kelly, Megan Passey, Rupendra Shrestha (2019) Informal caring for back pain: overlooked costs of back pain and projections to 2030. Pain 24 Dec 2019
doi: 10.1097/j.pain.0000000000001788 [epub ahead of printing]

D Schofield, M J B Zeppel, R Tanton, J L Veerman, S J Kelly, M E Passey, R N Shrestha (2019) Intellectual disability and autism: socioeconomic impacts of informal caring, projected to 2030. BJ Psych 215(5) p 654-660

Hannah Carter, Deborah Schofield, Rupendra Shrestha, Lennert Veerman (2019) The productivity gains associated with a junk food tax and their impact on cost-effectiveness. PLoS ONEv vol. 14, issue 7.

Deborah Schofield; Michelle Cunich; Rupendra Shrestha; Megan Passey; Lennert Veerman; Robert Tanton; Simon Kelly (2019) The Indirect Costs of Ischemic Heart Disease through Lost Productive Life Years for Australia from 2015 to 2030: results from a microsimulation model. BMC Public Health. 2019 19(1):802 DOI: B10.1186/s12889-019-7086-5

Schofield D, Cunich M, Shrestha R, Tanton R, Veerman L, Kelly S and Passey M (2019) Indirect costs of depression and other mental and behavioural disorders for Australia from 2015 to 2030. BJPsych Open. Vol 5(3), e40: 1-7, published online 3 May 2019

Deborah Schofield, Luke Rynehart, Rupendra Shresthra, Susan M White, Zornitza Stark (2019) Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management and reproductive outcomes. Genetics in Medicine 21(11) p2586-2593 DOI: 10.1038/s41436-019-0534-x

Lymer S, Schofield D, Colagiuri S, Shrestha R, Lee C (2019) The impact of weight-loss interventions on health expenditure in Australia: Evidence from a microsimulation model of obesity and chronic disease. Obesity Research & Clinical Practice 13 (1), 47

Zornitza Stark, Deborah Schofield, Melissa Martyn, Luke Rynehart, Rupendra Shrestha, Khurshid Alam, Sebastian Lunke, Tiong Y Tan, Clara L Gaff, Susan M White (2019) Does genomic sequencing early in the diagnostic trajectory make a difference?  A follow up study of clinical outcomes and cost effectiveness. Genetics in Medicine 21(1), 173-180 .

Hannah Carter, Deborah Schofield, Rupendra N Shrestha (2019) Productivity costs of cardiovascular disease mortality across disease types and socioeconomic groups. BMJ Open Heart  6(1) e000939

Deborah Schofield, Rupendra N Shrestha, Melanie J B Zeppel, et al (2019) Economic costs of informal care for people with chronic diseases in the community: lost income, extra welfare payments, and reduced taxes from 2015-2030. Health and Social Care in the Community 27(2): 493-501

2018

Schofield D J, Zeppel M J B, Tan O, Lymer S, Cunich M M & Shrestha R N (2018). A Brief, Global History of Microsimulation Models in Health: Past Applications, Lessons Learned and Future Directions. International Journal of Microsimulation, 11(1): 97-142

Shrestha R, Schofield D, Zeppel M J B, Cunich M M, Tanton R, Kelly S J, . . . Passey M E (2018). Care&WorkMOD: An Australian Microsimulation Model Projecting the Economic Impacts of Early Retirement in Informal Carers. International Journal of Microsimulation, 11(3) 78-99

Deborah Schofield, Michelle Cunich, Rupendra Shrestha, Robert Tanton, Lennert Veerman, Simon Kelly, Megan Passey (2018) The long-term economic impacts of arthritis through lost productive life years: results from an Australian microsimulation model. BMC Public Health 18(1):654

Lisa J Ewans, Deborah Schofield, Rupendra Shrestha, et al (2018) Whole Exome Sequencing Reanalysis at 12 Months Boosts Diagnosis and is Cost-effective When Applied Early in Mendelian Disorders. Genetics in Medicine. Published online 29 March 2018 doi:10.1038/gim.2018.39

Tan O, Shrestha R, Cunich M and Schofield D J (2018) Application of Next-Generation Sequencing to Improve Cancer Management: A Review of the Clinical Effectiveness and Cost-Effectiveness. Clin Genet, 93(3), 533-44

Elizabeth E Palmer, Deborah Schofield, Rupendra Shrestha, Tejaswi Kandula, et al (2018) Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy – evidence of clinical utility and cost effectiveness, Molecular Genetics and Genomic Medicine Published online 4 January 2018

Deborah Schofield, Rupendra Shrestha, Michelle Cunich (2018) The economic impacts of using adalimumab (Humira®) for reducing pain in people with ankylosing spondylitis: A microsimulation study for Australia International Journal of Rheumatic Diseases 21(5): 1106-1113

Schofield, D, Rynehart, L, Shrestha, R, White, SM & Stark, Z (2020), 'Response to Ferket et al.', Genetics in Medicine, vol. 22, no. 11, 1910. https://doi.org/10.1038/s41436-020-0889-z

Owen Tan, Rupendra Shrestha, Michelle Cunich, Deborah J Schofield (2018) Application of next generation sequencing to improve cancer management: A review of the clinical effectiveness and cost effectiveness Clinical Genetics 93:533-544

Tiong Tan, Oliver Dillon, Zornitza Stark, Deborah Schofield, Khurshid Alam, Rupendra Shrestha, et al (2017) Diagnostic impact and cost effectiveness of exome sequencing for ambulant children with suspected monogenic conditions JAMA Pediatrics 171 (9), 855-862

Deborah Schofield, Khurshid Alam, Lyndal Douglas, Rupendra Shrestha, Daniel MacArthur, Mark Davis, et al (2017) Cost-effectiveness of massively parallel sequencing for diagnosis of paediatric muscle diseases. npj Genomic Medicine 2(1):1-7

2017

Deborah Schofield, Rupendra Shrestha, Michelle Cunich, Megan Passey, Lennert Veerman, Robert Tanton (2017) The costs of diabetes among Australians aged 45–64 years from 2015 to 2030: projections of lost productive life years (PLYs), lost personal income, lost taxation revenue, extra welfare payments and lost gross domestic product from Health&WealthMOD2030 BMJ Open 7 (1), e013158

Hannah Carter, Deborah Schofield, Rupendra Shrestha (2017) The long term productivity impacts of all cause premature mortality in Australia Australian & New Zealand Journal of Public Health 41(2): 137-143 Nov 20 online

Deborah Schofield, Emily Callander, Simon Kelly, Rupendra Shrestha (2017) Working Beyond the Traditional Retirement Age: The Influence of Health on Australia’s Older Workers Journal of Aging and Social Policy 29 (3), 235-244

2016

Hannah Carter, Deborah Schofield, Rupendra Shrestha (2016) The productivity costs of premature mortality due to cancer in Australia: evidence from a microsimulation model PLOS ONE 11 (12), e0167521

Deborah Schofield, Michelle Cunich, Rupendra Shrestha, Rob Tanton, Lennert Veerman, Simon Kelly, Megan Passey (2016) The indirect costs of back problems (dorsopathies) in Australians aged 45-64 years from 2015 to 2030: results from a microsimulation model, Health&WealthMOD2030 Pain 157 (12), 2816-2825

Deborah Schofield, Rupendra Shrestha, Michelle Cunich, Rob Tanton, Lennert Veerman, Simon Kelly, Megan Passey (2016) The economic costs of chronic disease through lost Productive Life Years (PLYs) among Australians aged 45-64 years from 2015 to 2030: results from a microsimulation model BMJ Open 6:e011151

Emily Callander, Deborah Schofield, Rupendra Shrestha (2016) Higher education attainment does not improve the adult employment outcomes of adolescents with ill health Journal of Social Inclusion 7 (1), 49-58

Schofield D, Shrestha R, Cunich, M (2016) Measuring labour productivity and the benefits of interventions for osteoarthritis. Medicines Australia

Schofield D, Shrestha R, Cunich M, Callander E (2016) Keep on keeping on: Predicting who will be able to work until they are 70 years old. IRT Research Foundation Grants

Schofield D, Shrestha R, Cunich M (2016) The productivity impacts of Arthritis for patients and carers. Arthritis Australia

2015

Deborah Schofield, Rupendra Shrestha, Michelle Cunich, Rob Tanton, Lennert Veerman, Simon Kelly, Megan Passey (2015) Lost productive life years caused by chronic conditions in Australians aged 45-64 years from 2010 to 2030. Medical Journal of Australia 203 (6):260

Schofield D, Callander E, Shrestha R, Passey M, Kelly S, Percival R (2015) Multiple chronic health conditions and their link with wealth assets European Journal of Public Health, 25(2), 285-289

Deborah Schofield, Michelle Cunich, Simon Kelly, Megan Passey, Rupendra Shrestha, Emily Callander, Robert Tanton, Lennert Veerman (2015) The Impact of Diabetes on the Labour Force Participation, Savings and Retirement Income of Workers Aged 45-64 Years in Australia PLoS ONE 10(2): E0116860

Deborah Schofield, Emily Callander, Rupendra Shrestha, Megan Passey, Simon Kelly, Richard Percival (2015) Back problems, comorbidities and their association with wealth The Spine Journal 15(1) 34-41

Schofield D, Callander E, Shrestha R, Percival R, Kelly S, Passey M (2015) Labour force participation and the influence of having arthritis on financial status Rheumatology International 35 (7): 1175-1181

Veerman L, Shrestha R, Milalopoulos C, Passey M, Kelly S, Simon J, Tanton R, Callander E, Schofield D (2015) Depression prevention, labour force participation and income of older working aged Australians: a microsimulation economic analysis. Australian New Zealand Journal of Psychiatry 49(5):430-436.

Schofield D, Callander E, Shrestha R, Passey M, Kelly S, Percival R (2015) Multiple chronic health conditions and their link with wealth assets European Journal of Public Health, 25(2), 285-289

Deborah Schofield, Michelle Cunich, Simon Kelly, Megan Passey, Rupendra Shrestha, et al (2015) The Impact of Diabetes on the Labour Force Participation, Savings and Retirement Income of Workers Aged 45-64 Years in Australia PLoS ONE 10(2): E0116860

Deborah Schofield, Emily Callander, Rupendra Shrestha, Megan Passey, Simon Kelly, Richard Percival (2015) Back problems, comorbidities and their association with wealth The Spine Journal 15(1) 34-41

Schofield D, Callander E, Shrestha R, Percival R, Kelly S, Passey M (2015) Labour force participation and the influence of having arthritis on financial status Rheumatology International 35 (7): 1175-1181

2014

Carter H, Schofield D, Shrestha R (2014) LifeLossMOD: A Microsimulation Model of the Economic Burden of Premature Mortality in Australia The International Journal of Microsimulation 7(3): 33-52

Schofield D, Shrestha R, Kelly S, Veerman L, Tanton R, Passey M, Vos T, Cunich M and Callander E (2014) Health&WealthMOD2030: A microsimulation model of the long term economic impacts of disease leading to premature retirements of Australians aged 45-64 years The International Journal of Microsimulation 7(2):94-118

Deborah Schofield, Emily Callander, Rupendra Shrestha, Megan Passey, Simon Kelly, Richard Percival (2014) Multiple chronic health conditions and their link with wealth assets, European Journal of Public Health 25(2):285-9 Published online 5 September

Deborah Schofield, Michelle Cunich, Rupendra Shrestha, Megan Passey, Simon Kelly, Robert Tanton and Lennert Veerman (2014) The impact of chronic conditions of care recipients on the labour force participation of informal carers in Australia: Which conditions are associated with higher rates of non-participation in the labour force. BMC Public Health 14:561

Deborah Schofield, Michelle Cunich, Rupendra N Shrestha, Megan E Passey, Lennert Veerman, Emily J Callander, Simon Kelly and Robert Tanton (2014) The economic impact of diabetes through lost labour force participation on individuals and government: evidence from a microsimulation model, BMC Public Health14(1):1-8

Schofield D J, Callander E J, Shrestha R N, Passey M E, Percival R, Kelly S (2014) How co-morbidities magnify the effect of arthritis on labour force participation and economic status: a costs of illness study in Australia. Rheumatology International Apr; 34(4):481-489

Schofield D J, Cunich M, Shrestha R N, Passey M E, Veerman L, Kelly S (2014) The impact of diabetes on the labour force participation and income poverty of workers aged 45-64 years in Australia, PLoS One 9(2):e89360

Schofield D J, Callander E J, Shrestha R N, Passey M E, Percival R, Kelly S (2014) Indirect economic impacts of co-morbidities on people with heart disease. Circulation Journal 78(3): 644-8

2013

Schofield D, Shrestha, R, Percival R, Passey M Callander E, Kelly S (2013) The personal and national costs of CVD: impacts on income, taxes, government support payments and GDP due to lost labour force participation. International Journal of Cardiology 166(1): 68-71

Schofield D J, Callander E J, Shrestha R N, Passey M E, Percival R, Kelly S (2013) Multiple Chronic Health Conditions and Their Link with Labour Force Participation and Economic Status, PLoS ONE 8(11): e79108

Schofield D J, Callander E J, Shrestha R N, Passey M E, Kelly S, Percival R (2013) The impact of co-morbidities on the wealth of people with heart disease, International Journal of Cardiology 169(1), pp e12-e13

Schofield D, Callander E, Shrestha R, Passey M, Percival R, Kelly S (2013) Chronic health conditions and poverty: a cross-sectional study using a multidimensional poverty measure, BMJ Open 3(11):1-7 3:e003397

Pit S, Shrestha R, Schofield D, Passey M (2013) Partial and complete retirement due to ill-health among mature age Australians Public Health 127(6):561-71, available online http://dxdoiorg/101016/jbbr201103031

Schofield D, Callander E, Shrestha R, Passey M, Percival R, Kelly S (2013) Premature retirement due to ill health and income poverty: a cross-sectional study of older workers. BMJ Open; 3:e002683

Schofield D, Callander E, Shrestha R, Percival R, Kelly S, Passey M, (2013) The indirect economic impacts of co-morbidities on people with depression, Journal of Psychiatric Research 47(2013): 796-801

Schofield D, Shrestha R, Percival R, Passey M, Callander E, Kelly S (2013) The personal and national costs of lost labour force participation due to arthritis: an economic study. BMC Public Health 2013, 13:188

Schofield D, Shrestha R, Callander E, Byles J, Kimman M (2013) Costs of being a carer: Labour force participation and lost earnings among older working aged Australians, Australia New Zealand Journal of Public Health 37(2): 192-3

Schofield D, Callander E, Shrestha R, Percival R, Kelly S, Passey M (2013) The association between labour force participation and being in income poverty amongst those with mental health disorders, Ageing and Mental Health 17(2): 250-7

Fuller N, Colagiuri S, Schofield D, Olson A, Shrestha R, Holzapfel C, Wolfenstetter[Field] S, Holle R, Ahern A, Hauner H, Jebb S, and Caterson I (2013) A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial, International Journal of Obesity 37, 828–834

Callander, E, Schofield D, Shrestha R (2013) Freedom poverty: a new tool to identify the multiple disadvantages affecting those with CVD. International Journal of Cardiology 166(2): 321–326 Published online November 8 2011

2012

Schofield D, Shrestha R, Percival R, Passey M, Callander E, Kelly S (2012) The personal and national costs of early retirement due to spinal disorders: impacts on income, taxes, government support payments. The Spine Journal 12(12): 1111-8

Schofield D, Callander E, Shrestha R, Passey M, Percival R, Kelly S (2012) Association between co-morbidities and labour force participation amongst persons with back problems. Pain 153(10): 2068 - 2072

Kelly S, Schofield D, Shrestha R, Callander E, Richard R, Megan E (2012) The Impact of Illness on Retirement Finances. The Economic Record 88(283): 576 - 584

Callander, E, Schofield, D, Shrestha, R, Kelly, S (2012) Sufficient education attainment for a decent standard of living in modern Australia. Journal of Social Inclusion 3(1): 7 – 20

Callander E, Schofield D, Shrestha R (2012) Capacity for freedom - a new way of measuring poverty amongst Australian children. Child Indicators Research 5(12): 179 - 198

Schofield D, Shrestha R, Callander E (2012) Access to general practitioner services amongst underserved Australians: a microsimulation study. BMC Human Resources for Health 2012, 10:1

Schofield D, Callander E, Shrestha R, Percival R, Kelly S, Passey M (2012) Letter to the Editor regarding Kawadas comments on the paper Labour force participation and the influence of having CVD on income poverty of older workers. International Journal of Cardiology 157 (1):139 – 140

Callander E, Schofield D, Shrestha R (2012) Multiple disadvantages among older citizens: what a multidimensional measure of poverty can show. Journal of Aging & Social Policy 2012; 24(4): 368–383

Callander E, Schofield D, Shrestha R, Kelly S (2012) Health and functional capacity: Capturing capability limitations in measures of health. Health Sociology Review 21(3): 1624-47

Callander E, Schofield D, Shrestha R (2012) Capacity for freedom – using a new poverty measure to look at regional differences in living standards within Australia. Geographical Research 50 (4):411-420

Callander E, Schofield D, Shrestha R (2012) Multiple Disadvantages Among Older Citizens: What a Multidimensional Measure of Poverty Can Show. J Aging Soc Policy 24(4):368-383

Schofield D, Callander E, Shrestha, R, Percival R, Kelly S, Passey M (2012) Labour force participation and the influence of having back problems on income poverty in Australia. Spine 37(13): 1156-63

Callander E, Schofield D, Shrestha R (2012) Towards a holistic understanding of poverty: a new multidimensional measure of poverty for Australia. Health Sociology Review 21(2): 138 - 152

Schofield D, Callander E, Shrestha, R, Percival R, Kelly S, Passey M (2012) Labour force participation and the influence of having CVD on income poverty of older workers. International Journal of Cardiology 156(1):80-83

Schofield D, Kelly S, Shrestha R, Passey M, Callander E, Percival R (2012) The long term financial impacts of CVD: Living standards in retirement. International Journal of Cardiology 155(3): 406-8

Passey M, Shrestha R, Bertrand M, Schofield D, Vos T, Callander E, Percival R, Kelly S (2012) The impact of diabetes prevention on labour force participation and income of older Australians. BMC Public Health 2012, 12:16

Schofield D, Kelly S, Shrestha R, Callander E, Passey M, Percival R (2012) The Impact of Back Problems on Retirement Wealth. Pain 153(1):203-10

2011

Schofield D, Passey M, Percival R, Shrestha R, Callander E, Kelly S (2011) Retiring early with cardiovascular disease - impact on individual’s financial assets. International Journal of Cardiology 146(1): 125-126

Callander E, Schofield D, Shrestha R (2011) Multi-dimensional poverty in Australia and the barriers ill health imposes on the employment of the disadvantaged. Journal of Socio-Economics 40(6): 736–742

Schofield D, Shrestha R, Passey M, Fletcher S, Kelly S and Percival R (2011) Projecting the Impacts of Illness on Labour Force Participation: An Application of Health&WealthMOD. International Journal of Microsimulation 4(3) 37-47

Schofield D, Shrestha R, Callander E, Percival R, Kelly S, Passey M and Fletcher S (2011) Modelling the cost of ill health in Health&WealthMOD (Version II): Lost Labour Force Participation, Income and Taxation and the Impact of Disease Prevention. International Journal of Microsimulation 4(3) 32-36

Schofield D, Shrestha R, Percival R, Passey M, Kelly S, Callander E (2011) Economic Impacts of Illness in Older Workers: Quantifying the impact of illness on income, tax revenue and government spending. BMC Public Health 11:418

Schofield D, Kelly S, Shrestha R, Callander E, Percival R, Passey M (2011) How depression and other mental health problems can affect future living standards of those out of the labour force. Aging and Mental Health15(5): 654-662

Schofield D, Shrestha R, Percival R, Callander E, Kelly S, Passey M (2011) Early retirement and the financial assets of individuals with back problems. European Spine Journal 20(5): 731-736

Schofield D, Shrestha R, Percival R, Passey M, Callander E, Kelly S (2011) The personal and national costs of mental health problems: impacts on income, taxes and government support payments due to lost labour force participation. BMC Psychiatry 11:72

Schofield D, Kelly S, Shrestha R, Callander E, Percival R, Passey M (2011) Quantifying the effect of early retirement on the wealth of individuals with depression or other mental illness. British Journal of Psychiatry 198:123-128

2010

Schofield D, Percival R, Passey M, Shrestha R, Callander E, Kelly S (2010) The financial vulnerability of individuals with diabetes. British Journal of Diabetes and Vascular Disease 10(6): 300-304

Schofield D, Percival R, Passey M, Shrestha R, Kelly S (2010) The financial vulnerability of individuals with diabetes: Reduced wealth available to individuals with diabetes. British Journal of Diabetes and Vascular Disease (Middle Eastern Edition) 10(6): 300-304

Schofield D, Fletcher S, Page S, Callander E, and Shrestha R (2010) How well prepared are Australian dentists for retirement? A survey of practitioners aged 50 and above. International Dental Journal 60(4):285-92

Pit S, Shrestha R, Schofield D, Passey M (2010) Health problems and retirement due to ill-health among Australian retirees aged 45-64 years. Health Policy 94 (2010) 175–181

2009

Schofield D, Passey M, Earnest A, Percival R, Kelly S, Shrestha R, Fletcher S (2009) Health&WealthMOD – A Microsimulation Model of the Economic Impacts of Diseases on Older Workers: Costs to Government and Individuals and Opportunities for Intervention. International Journal of Microsimulation 2(2): 58-63

Schofield D, Keane S, Fletcher S, Percival R, Shrestha R (2009) Loss of income and levels of scholarship support for students on rural clinical placements: A survey of medical, nursing and allied health students. Australian Journal of Rural Health 17(3): 134-40

2008

Schofield D, Shrestha R, Passey M, Earnest A, Fletcher S (2008) Chronic disease and labour force participation among older. Australians Medical Journal of Australia 189 (8): 447-450

Schofield D, Fletcher S, Earnest A, Passey M, Shrestha, R (2008) Where are older workers with chronic conditions employed? Medical Journal of Australia 188 (4): 231-234

Schofield D, Passey M, Earnest A, Gloor I, Shrestha R (2007) Are We Getting Healthier As We Grow Older? Implications for baby boomer labour force participation Ed by Weller; N Weller; J Weller C Annals of the New York Academy of Sciences (Ann NY Acad Sci) Proceedings from the Healthy Aging and Longevity: Third International Conference Vol 1114, issue 1, 230-240

Fisher G, Kjellstrom T, Kingham S, Hales S and Shrestha R (2007) Health and air pollution in New Zealand: Main report. Health Research Council, Ministry for the Environment, Ministry of Transport: Wellington

2006

Kjellstrom T, Madhumita L, McMichael T, Ranmuthagala G, Shrestha R and Kingsland S (2006) Air and water pollution: Burden and strategies for control, in Disease control priorities in developing countries, D T Jamison, J G Breman, A R Measham, G Alleyne and M Claeson (editors). World Bank: Washington DC p 817-832

Milton A H, Rahman H, Smith W, Shrestha R and Dear K (2006) Water consumption patterns in rural Bangladesh: are we underestimating total arsenic load? J Water Health. 4(4): 431-6

2005

Fisher G, Kjellstrom T , Woodward A, Hales S, Town I, Sturman A, Kingham S, O'Dea D, Wilton E, O'Fallon C, Scoggins A, Shrestha R, Zawar-Rewa P, Epton M, Pearce J, Sturman J, Spronken-Smith R, Wilson J, McLeod S, Dawson R, Tremblay L, Brown L, Trout K, Eason C  and Donnelly P  (2005) Health and air pollution in New Zealand: Christchurch pilot study Health Research Council, Ministry for the Environment, Ministry of Transport: Wellington

2004

Hoque E, Hope V, Scragg R, Baker M and Shrestha R (2004) A descriptive epidemiology of giardiasis in New Zealand and gaps in surveillance data. N Z Med J. 117(1205): U1149

2002

Fisher G W , Rolfe K A , Kjellstrom T , Woodward A , Hales S , Sturman A P , Kingham S , Peterson J , Shrestha R  and King D  (2002) Health effects due to motor vehicle air pollution in New Zealand  Ministry of Transport: Wellington

Grants and Funding

Thomas R, March L, Rossjohn J, Buchbinder R, Cope A, Isaacs J, Wachelakar M, Thurecht K J, Schofield D, Shrestha, R (2024) MRFF Frontier Health and Medical Research Initiative 2022: Reset Rheumatoid Arthritis Project. $11.54 million over 5 years.

Deborah Schofield,  Robyn Jamieson, David Mackey, John Grigg, Fred Chen, Rupendra Shrestha, Lauren Ayton, Alan Ma, Andrea Vincent, Bruce Bennetts, Alexis Ceecee Britten-Jones, Emma Hackett, Matthew Simunovic, Jinjing Li, Heather Mack, Benjamin Nash, Elisa Cornish, Thomas Edwards, Jan Mumford (2024) Translation of precision medicine into clinics for genetic blindness: from diagnosis to clinical management and therapies. NHMRC Partnership Grant (APP2027453) $1,496,744 over 5 years.

Kathy Wu, Sophie Devery, Nick Babidge, Sarah Michael, Ric O Day, Jonathan Brett, Jane Carland, Sophie Stocker, Terry Melacco, Deborah Schofield, Rupendra Shrestha, Heidi Worsley (2020) Towards Implementation of pharmacogenomics-guided therapy in Patients with Mental Illness. St Vincent’s Health Australia Ltd. $395,070 over 2 years

Kathy Wu, Paul Fitzgerald, Deborah Schofield, Stuart Grieve, Rodgers, Anthony Harris, Rupendra Shrestha, Sean Hood, Timothy Usherwood, Fatemeh Vafaee (2020) An Australian Multicentre Double-Blinded Randomised Controlled Trial of Genotype-guided versus Standard Psychotropic Therapy in Moderately-to-Severely Depressed Patients Initiating Pharmacotherapy. Medical Research Future (MRFF) $2.95 million over 4 years.

Deborah Schofield, Rupendra Shrestha, Owen Tan, Sarah West, Heidi Worsley (2020) Zero Childhood Cancer Health Economic Sub-Study: Understanding the cost of personalised cancer care in children – Part 2. Children’s Cancer Institute Australia/Luminesce Alliance $400,000 25/5/20-20/7/22

Deborah Schofield,Mike Field, Rupendra Shrestha, Tony Roscioli, Owen Tan, Jan Mumford, Jackie Boyle, Louise Christie, Heidi Worsley. (2020) Cascade testing in intellectual disability: social and economic impact. Genomic Health Future Mission (MRFF), $486,897 over 3 years

Deborah Schofield, Jacob Veerman, Rupendra Shrestha, Simon Kelly, Robert Tanton (2020) Develop a highly innovative microsimulation model: Health&WorkMOD to quantify the costs of health-related productivity loss due to chronic illness. ARC Discovery Project Scheme DP200100726. $444,353.

Melanie Zeppel, Deborah Schofield, Rupendra Shrestha, Sophie Lewis, Sarah Perkins (2020) Costs of heat waves on health: vulnerable communities and regions. 20-22 MQ Research Seeding Grant M Zeppel 110378583 IntFun, $26,898, 2020-2022

Kathy Wu, Deborah Schofield,  Rupendra Shrestha (2019) Informing resource needs of pharmacogenomics-guided therapy in patients with mental illness or alcohol use disorder: for SVHA campus-wide implementation and beyond. SVHA Inclusive Health Innovation Fund Steering Committee. $395,070.

Deborah Schofield, Tracey O'Brien, Claire Wakefield, Michelle Haber, Rupendra Shrestha, Glenn Marshall, Katherine Tucker, Luciano Dalla-Pozza, David Ziegler, Toby Trahair, Nick Gottardo, Loretta Lau, Vanessa Tyrell, Wayne Nicholls, Jordan Hansford, Heidi Worsley (2018) The economic impact of precision medicine in high risk and aggressive childhood cancer. NHMRC Partnership Project (APP1159004) $1,351,693 over five years. $2,668,750 in kind.

Edwin Kirk, Martin Delatycki, Nicholas Pachter, Nigel Laing, Kristine Barlow-Stewart, Deborah Schofield, Michelle Farrar, Damien Bruno, Sebastian Lunke, John Beilby, Mark Davis, Michael Fietz, Ainsley Newson, David Amor, Stephen Robson, Michael Buckley, Tony Roscioli, John Massie, Alison Archibald, Cliff Meldrum, Julie McGaughran, Jan Liebelt, Chiyan Lau, Janice Fletcher, Alison Colley, Kate Dunlop, Rupendra Shrestha, Meredith Wilson (2018) The Australian Reproductive Carrier Screen Project. Medical Research Future Fund $20,000,000.

Deborah Schofield, Roula Ghaoui, Rupendra Shrestha, Carolyn Sue, Heidi Worsley (2018) Evaluating the cost-effectiveness of whole genome sequencing for the diagnosis of the mitochondrial disease. Australian Mitochondrial Disease Foundations $150,000.

Deborah Schofield, Owen Tan, Rupendra Shrestha, Melanie Zeppel (2018) The costs of childhood cancer, Children’s Cancer Institute $200,000.

Deborah Schofield, Carolyn Sue, Tony Roscioli, John Mattick, Marcel Dinger, Rupendra Shrestha, Michael Buckley, Ryan Davis (2018) The economic impact of providing precision medicine through whole genome sequencing. NHMRC Partnership Project (APP1151906) $1,144,787.50 over 5 years plus partner funding.

Deborah Schofield, Nigel Laing, Martin Delatycki, Marcel Dinger, Tony Roscioli, Edwin Kirk, Michael Field, Rupendra Shrestha, Damien Bruno, Simon Kelly, Heidi Worsley (2017). Preconception carrier screening: providing genetically at risk families with a chance to have healthy children. NHMRC Partnership Project (APP1146134) $845,827.40 over 5 years plus partner funding.

Louisa Gordon, Nicholas Grave, Penelope Webb, Deborah Schofield, Rupendra Shrestha, Khurshid Alam, Owen Tan, Luke Rynehart, Sharyn Lymer, Sarah West (2017) Evaluation of clinical genomics projects in action. Queensland Genomics Health Alliance (QGHA) Round 1 Project Fund. $480,000 over 2 years.

Schofield D, Roscioli T, Mattick J, Kasparian N, Dinger M, Barlow-Stewart K, Cowley M, Field M, Buckley M, Shrestha R (2016) The economic and social impacts of genetic sequencing for intellectual disability. (APP1113895) NHMRC Partnership Grant. $1,263,576 over 5 years.

Schofield D, Shrestha R, Cunich, M (2014) Measuring labour productivity and the benefits of interventions for osteoarthritis, Medicines Australia, $243,000.

Schofield D, Shrestha R, Cunich M (2014) Keep on keeping on: Predicting who will be able to work until they are 70 years old. IRT Research Foundation Grants. $84,000.

Schofield D, Shrestha R, Cunich M (2014) The productivity impacts of Arthritis for patients and carers. Arthritis Australia. $125,000.

Schofield D, Shrestha R (2013) Modelling the economic impacts of an intervention for ankylosing spondylitis. Abbott Laboratories Australia $100,000.

Deborah Schofield, Theo Vos, Simon Kelly, Megan Passey, Rupendra Shrestha, Rob Tanton, Mendel Grobler (2012) Improving decision making on health interventions: factoring in the long term economic impacts of informal (unpaid) care. NHMRC Partnership Project Grant $1,100,000 over three years. (APP1055037).

Schofield D, Shrestha R, Verry H, Yarbrough J, Callander E (2012) Two scoping studies: 1. Economic impacts of an intervention for ankylosing spondylitis, 2. Including productivity impacts in a utility measure. Abbott Laboratories Australia $95,000

Schofield D Callander E Shrestha R Kelly S (2012) Working Beyond the Traditional Retirement Age: Quantifying the Benefits for Retirement Savings. National Seniors Australia Productive Ageing Grants $40,000.

John Buchanan, Phil Bohle, Deborah Schofield, Stephen Colagiuiri, Ian Hickie, Nick Glozier, Tim Shaw, Stephen Leeder, Ron Grunstein, Joellen Riley, Richard Johnstone, Michael Quinlan, Toni Schofield, Mairwen Jones, Lynda Matthews, Tony Grant, Sandra West, Tim Chen, Daniel Nyberg, Rupendra Shrestha, Toby Fattore, Linda Scott, Martha Knox, and Maria McNamara (2012) Health and work research network. University of Sydney Research Networks Scheme (SyReNS), The University of Sydney, $230,000.

Emily Callander, Deborah Schofield and Rupendra Shrestha (2011) The Effect of Higher Education on the Future Social Participation Opportunities of Children with Poor Health 2011 USYD Widening Participation Grants Program $24,800.

Deborah Schofield and Rupendra Shrestha In confidence $12,500 Department of Health and Ageing

Deborah Schofield and Rupendra Shrestha (2011) Determination of the economic impact of Lyrica. Pfizer Australia $133,405.

Walton M, Page S, Schofield D, et al (2006) NSW Doctors: A workforce study of the International Medical Workforce, NSW Health $100,000

Lyle D, Frager L, Beard J, Kelly B, Schofield D Passey M, et al. (2006) Australian Rural Health Research Collaboration, Research and Development Capacity Building Infrastructure Grants Program, NSW Health $1.5 mill

Deborah Schofield (2006), Workforce analysis, Southern Cross University, May 2006 ($6,000)

Deborah Schofield (2006), Policy advice in confidence, The Department of Treasury, 7-8 February 2006 ($3,177 plus travel and in kind costs)

Deborah Schofield and Jeff Fuller (2006), The future of the regional health workforce. University of Sydney R&D Program, ($43,269)